DelveInsight’s, “ Idiopathic Pulmonary Fibrosis Pipeline Insights 2025 ” report provides comprehensive insights about 80+ ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...

Researchers in China used machine learning to create diagnostic and prognostic models to aid in identifying idiopathic ...

New 3D tissue model offers a breakthrough tool for understanding and treating scleroderma and other fibrotic diseases.

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and sometimes fatal illness ...

Traditional lab and animal studies cannot reflect scleroderma’s complexity. But now researchers from Tufts University and Geisel School of Medicine at Dartmouth have developed a new 3D tissue model, ...

The Company hypothesized that NV-387 could be effective against Measles because NV-387 was previously found to completely cure RSV lung infection in a lethal animal model.

Exposure to a common fungal molecule can reprogram immune cells in the lungs, causing them to overreact to infection-like signals and worsen lung damage, according to new research.

Serious chronic lung fibrosis like idiopathic pulmonary fibrosis is marked by increasing difficulty to breathe. The UAB researchers showed that TREM2 — which stands for triggering receptors expressed ...

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood cells that defend the body by killing microbes, removing dead cells ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.